Brain Injury Lawyer

I recently read an interesting article on the International Brain Injury Association’s website discussing the notably difficult task of developing drug treatments for patients suffering from traumatic brain injuries. The article, written by Neal M. Farber, PhD, CEO of NeuroHealing Pharmaceuticals, Inc., states that most clinical trials for possible pharmaceutical treatments for traumatic brain injuries have been driven by pharmaceutical and biotech companies. Farber goes on to state that there is an active need for physicians, researchers and the pharmaceutical industry to bolster efforts to help develop much needed and more effective drug therapies for treating patients with traumatic brain injuries. 

You can read Farber’s full article online here.